{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-008311","form_type":"8-K","ticker":"AVAH","cik":"0001832332","company_name":"Aveanna Healthcare Holdings, Inc.","filed_at":"2023-03-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.923484+00:00","generated_at":"2026-06-18T00:56:49.551571+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Aveanna Q4 revenue +9% to $451.1M; net loss widens to $237.8M on $87.4M goodwill impairment","bullets":["Q4 revenue $451.1M (+9% YoY); net loss $237.8M vs $126.2M loss in Q4 2021 due to $87.4M impairment.","Adjusted EBITDA $29.7M (6.6% margin), down 35% from $45.8M (11.1% margin) a year ago.","FY 2022 revenue $1,787.6M (+6.5%); net loss $662.0M, including $557.6M non-cash impairment charges.","FY 2022 adjusted EBITDA $129.3M vs $184.2M; adjusted EPS $0.00 vs $0.42 in FY 2021.","Cash $19.2M; revolver undrawn with $180M capacity; free cash flow deficit $81.5M for FY 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-008311","json":"https://secwatch.observer/filing/0000950170-23-008311.json","markdown":"https://secwatch.observer/filing/0000950170-23-008311.md","text":"https://secwatch.observer/filing/0000950170-23-008311.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/avah-20230316.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-18T00:56:49.551571+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"19b8f78466b8c1dffa36a6d36c41b03e41e7874e","claim":"Aveanna Healthcare Holdings, Inc. reported the three-month period ended December 31, 2022 results: revenue $451.1 million, net income $237.8 million, EPS $1.28.","evidence_excerpt":"Revenue was $451.1 million for the three-month period ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three-month period ended December 31, 2022"},{"label":"Revenue","value":"$451.1 million"},{"label":"Net income","value":"$237.8 million"},{"label":"EPS","value":"$1.28"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"2fe3ab6afd878b09c2db777f1abf7b7a6086d214","claim":"Aveanna Healthcare Holdings, Inc. reported the three-month period and fiscal year ended December 31, 2022 results: revenue $451.1 million, net income $237.8 million, EPS $1.28.","evidence_excerpt":"Item 2.02. --- EX-99 (EX-99.1) --- EX-99 Exhibit 99.1 AVEANNA HEALTHCARE HOLDINGS ANNOUNCES FOURTH QUARTER AND FULL YEAR 2022 FINANCIAL RESULTS • Revenue increased 9.0% to $451.1 million, compared to Q4 2021 o Gross margin increased 3.5% to $128.8 million, compared to Q4 2021 • Net loss was $237.8 million, compared to net loss of $126.2 million in Q4 2021 o","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the three-month period and fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$451.1 million"},{"label":"Net income","value":"$237.8 million"},{"label":"EPS","value":"$1.28"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"59630abce01a9986cddc8458348a38d83666197a","claim":"Aveanna Healthcare Holdings, Inc. reported the fiscal year ended December 31, 2022 results: revenue $1,787.6 million, net income $662.0 million, EPS $3.57.","evidence_excerpt":"Revenue was $1,787.6 million for the fiscal year ended December 31, 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1832332/000095017023008311/0000950170-23-008311-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fiscal year ended December 31, 2022"},{"label":"Revenue","value":"$1,787.6 million"},{"label":"Net income","value":"$662.0 million"},{"label":"EPS","value":"$3.57"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}